A biotech startup has successfully used an AI agent to perform a gene therapy injection on a live mouse, marking a significant step towards AI's active participation in laboratory research. The AI agent, initially tested with Anthropic's Claude Opus 5.5 but switched to Claude Sonnet 5 due to refusal, selected the therapy, brain region, and injection parameters. This experiment, conducted by Gabriel Ocana Santero of Exin Therapeutics, aims to integrate AI more deeply into scientific processes, moving beyond planning and analysis to direct experimental execution. AI
IMPACT Demonstrates AI's potential to actively participate in laboratory research, moving beyond planning to direct experimental execution.
RANK_REASON AI agent performing a novel experimental procedure on a live subject in a research setting.
Read on Mastodon — mastodon.social →
- Anthropic
- Claude Opus 5.5
- Claude Sonnet 5
- epilepsy
- Exin Therapeutics
- Gabriel Ocana Santero
- gene therapy
- AI agent
- Neurodegenerative Diseases
- San Francisco
- Wired
AI-generated summary · Google Gemini · from 6 sources. How we write summaries →